###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
Pvt1-encoded microRNAs in oncogenesis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
The functional significance of the Pvt1 locus in the oncogenesis of Burkitt's lymphoma and plasmacytomas has remained a puzzle. In these tumors, Pvt1 is the site of reciprocal translocations to immunoglobulin loci. Although the locus encodes a number of alternative transcripts, no protein or regulatory RNA products were found. The recent identification of non-coding microRNAs encoded within the PVT1 region has suggested a regulatory role for this locus.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
The mouse Pvt1 locus encodes several microRNAs. In mouse T cell lymphomas induced by retroviral insertions into the locus, the Pvt1 transcripts, and at least one of their microRNA products, mmu-miR-1204 are overexpressed. Whereas up to seven co-mutations can be found in a single tumor, in over 2,000 tumors none had insertions into both the Myc and Pvt1 loci.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
Judging from the large number of integrations into the Pvt1 locus - more than in the nearby Myc locus - Pvt1 and the microRNAs encoded by it are as important as Myc in T lymphomagenesis, and, presumably, in T cell activation. An analysis of the co-mutations in the lymphomas likely place Pvt1 and Myc into the same pathway.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1</italic>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 968 972 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1080 1084 1080 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1130 1134 1130 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1178 1182 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1281 1285 1281 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1312 1313 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1386 1391 1386 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 1405 1406 1405 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1407 1408 1407 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 57 63 <span type="species:ncbi:9606">humans</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
Ever since its discovery in 1984 [1], the Pvt1 locus (in humans PVT1, for plasmacytoma variant translocation) has remained enigmatic. Although human and mouse PVT1 directs the synthesis of a large transcript, which gives rise to a variety of RNAs in normal cells [2-4], no protein product or regulatory RNA were identified. Nevertheless, the importance of the PVT1 locus is gleaned from the observations that it is the site of both tumorigenic translocations and retroviral insertions. In Burkitt's lymphoma, the so-called 'variant' translocations, T(2:8) or T(8:22), found in about 20% of such tumors, juxtapose immunoglobulin kappa or lambda light chain genes to the PVT1 locus. This results in chimeric transcripts of 0.9 to 1.2 kilobase (kb), containing the first exon of PVT1 on chromosome 8 and the constant region of kappa or lambda [4,5]. Although the chimeric transcripts might contribute to tumor formation, an oncogenic effect could also be mediated by the MYC protooncogene, just 40 to 60 kb upstream. Indeed, 80% of the translocations in Burkitt's lymphoma juxtapose MYC to the immunoglobulin heavy chain locus, with MYC being overexpressed as a consequence. Since MYC is also overexpressed in cells with variant translocations, it has been thought that activation of MYC may occur either directly [4], at a remarkable distance along the chromosome, or indirectly, via the PVT1 gene product [3,6].
###end p 9
###begin p 10
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 126 132 <span type="species:ncbi:10090">murine</span>
In multiple myeloma, 16% of patients have the PVT1 region rearranged, but independent of the immunoglobulin loci [7]. In most murine plasmacytomas, t(15:12) translocations, analogous to the T(8:14) translocations in Burkitt's lymphoma, fuse the 5' end of the c-Myc gene to an immunoglobulin heavy-chain gene; there are also the t(6:15) translocations, where the chromosome 6 breakpoint is near the constant region of kappa and the chromosome 15 sequences are from the Pvt1 locus [1,6]. In these plasmacytomas, the expression of the (truncated) Pvt1 transcripts is increased [3].
###end p 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 53 74 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 76 79 <span type="species:ncbi:11786">MLV</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10116">rats</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 974 977 <span type="species:ncbi:11786">MLV</span>
Pvt1 is also a common retroviral integration site in murine leukemia virus (MLV) induced T lymphomas in mice [8] and rats [9,10]. Common integration sites identify protooncogenes and tumor suppressor genes, because the provirus not only acts as a mutagen, but it also "tags" the integration site with its own sequences [11]. The so-called proviral tagging method has been used to identify many new protooncogenes as well as to confirm already known protooncogenes discovered by virtue of their homology to viral oncogenes, and entire genomes have been searched for genes involved in cancer development [12-21]. These genes include non-coding RNA [22], such as oncogenic microRNAs (miRNAs) [23-25], for which models in viral oncogenesis have been described [26]. In the proviral tagging method, mice are infected with a oncogenesis have been described [26]. In the proviral tagging method, mice are infected with a retrovirus that does not contain any oncogene (for example, MLV). The virus integrates into the cellular genome and inserts its DNA near or within genes, which leads to various outcomes: (i) The insertion site is too far away from a protooncogene and thus does not activate it. In this case, there will be no selection for that cell. (ii) The provirus inserts near a protooncogene, but not within the gene (type 1). In this case, either the viral promoter, or the viral enhancer increases the expression level of the protooncogene. (iii) The provirus inserts within a gene, destroying or altering its function (type 2). In both type 1 and type 2 insertion events, if the gene is not a protooncogene or tumor suppressor gene, there will be no selection for that cell. If integration results in formation of a tumor, genomic DNA adjacent to the integration site can be recovered, sequenced and mapped to the genome. Genes neighboring the proviral integration can then be identified and classified as either protooncogenes or tumor suppressor genes.
###end p 11
###begin p 12
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 66 69 <span type="species:ncbi:11786">MLV</span>
###xml 566 569 <span type="species:ncbi:11786">MLV</span>
In a large-scale retroviral insertion mutagenesis screen, we used MLV strain SL3-3, which causes T lymphomas [27]. We previously demonstrated that a group of these retroviral insertions induces overexpression of the oncogenic mmu-mir-17 miRNA cistron [23] and mmu-mir-106a [24], among other miRNAs. The Pvt1 locus is among the top targets of retroviral insertions in T lymphomas, but it encodes transcripts with no known protein product. Recently, PVT1 based miRNA candidates have been identified and confirmed experimentally [28], and here we studied the effect of MLV integration on the expression of Pvt1 and the miRNAs. By virtue of being tagged by the retrovirus that mediated tumor formation, these miRNAs could then be defined as oncogenic.
###end p 12
###begin title 13
Results and Discussion
###end title 13
###begin title 14
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Retroviral integrations into the Myc and Pvt1 loci
###end title 14
###begin p 15
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 667 672 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 819 824 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 883 884 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1055 1059 1055 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1082 1087 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 420 425 <span type="species:ncbi:10090">Mouse</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 856 859 <span type="species:ncbi:11786">MLV</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10116">rats</span>
###xml 1001 1004 <span type="species:ncbi:11786">MLV</span>
We identified 6234 integration sites, or tags, in 2199 T-cell tumors. In these tumors, 243 tags were located at or near the Pvt1 locus, distributed over a region of 679,620 bp; additionally 134 tags were located at the Myc locus, distributed over 105,445 bp (Fig. 1). The proviral inserts were in both sense and anti-sense orientations with respect to each transcript encoded by the Myc and Pvt1 loci, respectively. The Mouse Retroviral Tagged Cancer Gene Database [29], which compiles retroviral insertions into the genomic DNA from various non-T cell derived mouse tumors, also lists 37 integrations when searched by the Myc locus, some of which are in fact in the Pvt1 locus. Insertions at the Pvt1 locus were originally reported in myelogenous mouse leukemia [29], and, as mentioned above, in the work defining the Pvt1 locus in T lymphomas induced by MLV in both mice and rats [8-10]. Remarkably, in a separate screen (data not shown) where we recovered 1798 tags from B lymphomas induced by the MLV strain Akv [15,30], only one tag was found at the Myc locus, and none at the Pvt1 locus.
###end p 15
###begin p 16
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>Pvt1 </italic>and the <italic>Myc </italic>loci have separate and distinct common integration sites</bold>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 618 623 <span type="species:ncbi:10090">mouse</span>
The Pvt1 and the Myc loci have separate and distinct common integration sites. Screen print of a customized version of the UCSC genome website browser (mouse February 2006 (mm8) genome assembly) depicting the Myc and the Pvt1 locus in the mouse. Numbers at the top, nucleotide position at chromosome 15. Green squares indicate insertion sites. Below them are the exon-intron structures of Myc and Pvt1, respectively. Pvt1 is represented by two reference sequences, AK090048 and Z11981, which do not share any sequence homology, but there are other transcripts as well: Below the reference sequences, there are various mouse mRNAs from GenBank. In this representation, the myc exons (thin vertical bars) are compressed. Introns are represented by horizontal lines, with the arrows denoting direction of transcription. Myc transcription is from left to right, and most Pvt1 transcripts are also from left to right.
###end p 16
###begin p 17
###xml 5 6 5 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 895 900 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Fig. 1 shows a customized screen print of the UCSC genome web site browser, looking at the Myc and Pvt1 loci. The bars in green represent the retroviral insertions in T lymphomas studied here; below them are the exon-intron structures of Myc and Pvt1, respectively. At the Myc locus, there are two main integration sites clusters flanking the gene upstream and downstream of it. Whereas the Myc transcript is clearly defined, there are several alternative transcripts depicted for Pvt1, a variety that was noted before [2-4]. Notably, there are two reference sequences, AK090048 and Z11981, which do not share any sequences, but are denoted as Pvt1 nevertheless. Furthermore, among the mRNAs from GenBank, there are other fragments of apparently intronic transcripts, and there is AK030859, which represents an extended exon 1. At any rate, there are three main integration site clusters at the Pvt1 locus, as represented by transcript AK090048 - one upstream of the transcript, and two within the locus.
###end p 17
###begin title 18
Transcriptional orientation of provirus and target gene
###end title 18
###begin p 19
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 647 651 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 935 939 935 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 992 996 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1094 1098 1094 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1320 1324 1320 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1363 1368 1363 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
When a genomic region is gene-rich, it is not always straightforward to identify the target gene of insertional mutagenesis. In the past, it has been assumed that the retroviral enhancer can act over a distance of 200 kb in either direction, but without "leapfrogging" a gene promoter. With this assumption, because one of the proximal promoters will always be the retroviral promoter, the orientation of the provirus in regard to the direction of transcription of the gene will be important. Indeed, the two integration clusters into the Myc locus are an example of this prediction: the direction of transcription of the provirus upstream of the Myc gene always points away from the gene (Fig. 2A; with the exception of the three insertions, boxed in red, which presumably are "promoter insertions," i.e., the transcript is driven by the viral promoter rather than the endogenous promoter). In contrast, the cluster downstream of the Myc locus contains proviruses in the same orientation as Myc (Fig. 2B). In both cases, this arrangement allows the retroviral 5' enhancer to interact with the Myc promoter, although other interpretations are viable (see below). Because of the rule that the retroviral enhancer does not "leapfrog" promoters, but synergizes with the two promoters next to it, the two clusters targeting Myc are not expected to directly influence Pvt1 transcription, 50 kb downstream.
###end p 19
###begin p 20
###xml 28 32 28 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 70 74 70 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
Higher magnification of the (A) 5' flanking (upstream of exon 1), and (B) 3' flanking region of Myc. The handle bars in green represent the retroviral insertions; arrows in the line within the bars denote direction of provirus transcription. Proviruses boxed in red are in the same orientation as the Myc gene (from left to right), opposite from the rest. Proviruses are in the same orientation as the Myc gene.
###end p 20
###begin p 21
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1012 1017 <span type="species:ncbi:10090">mouse</span>
The criterion of orientation does not hold in an immediately obvious way if a virus integrates into a transcription unit, as it does at the Pvt1 locus. In this case, especially as many alternative transcripts have been identified, the exact location of the retrovirus - 5'UTR, 3'UTR, intron, or exon is important. Apart from the retroviral enhancer cooperating with the gene promoter in a conventional manner, the retroviral promoter may override the endogenous promoter, or it may initiate a (truncated) transcript, in addition to truncating or destroying one. If the provirus is located with the UTR, it may also affect mRNA stability, although in that case no preference in proviral orientation would be obvious. If the Pvt1 nuclear (primary) transcript encodes miRNAs, we cannot predict the likely consequence of a particular integration - whether the steady-state levels of all or only a few miRNAs change. A low level of Pvt1 transcript does not necessarily mean little miRNA product. For example, NIH-3T3 mouse fibroblasts express very little primary RNA of the mir-17-20 cistron, but as much mature mir-17-3p as T cell tumors with retroviral integrations into the primary transcript [23]. This points to the possibility that retroviral insertions do not always have to increase the levels of primary transcripts in order to produce more mature product; instead they might make the processing of miRNA from the primary transcript more efficient.
###end p 21
###begin title 22
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Overexpression of Pvt1 transcript
###end title 22
###begin p 23
###xml 5 6 5 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 870 871 870 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 940 945 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1023 1028 1023 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1060 1062 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1496 1501 1496 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1585 1586 1585 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1655 1656 1655 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
Fig. 3 shows a higher magnification of the area around exon 1 of Pvt1, where a main cluster of 78 integrations is located. Because a plurality of the Pvt1 integrations clustered around exon 1, we determined the expression levels of that exon (exon 1a) in various tumors by quantitative PCR, using a primer set that covered the 5' end of this exon (see boxed area in transcript AK030859 depicted in Fig. 3; the 5' end of the exon representing AK030859 is shared with exon 1 of the reference sequence AK090048). Of the tumors with integrations shown in Fig. 3, the designations of tumors we selected are shown in bold face type, and are numbered (1) through (28) (only tumors 1 through 24 are shown in Fig. 3; the integration sites of these tumors, and all other tumors studied here, along with the relative transcription orientation of the proviruses, are given in Table 1). As compared to control tumors, which have no integration into the Pvt1 locus, most tumors with the integrations selected in Fig. 3 overexpressed the Pvt1 transcript, up to 40-fold (Fig. 4A). Tumors 10 through 28, with insertions starting right at the 3' boundary of the first exon, mostly overexpress Pvt1 with a few exceptions (tumors 13, 17, and 19). We have noticed that the direction of transcription of the proviruses in tumors 13 and 19 is opposite of all the others in that group (see above for discussion of provirus transcriptional orientation). Tumors 1 through 9, with insertions located 5' to exon 1a, express Pvt1 at levels similar to the control tumors (the control tumors are not listed in Table 1). They possibly overexpress transcripts starting with exon 1b (Fig. 5), although we have not tested this assumption.
###end p 23
###begin p 24
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Higher magnification of the area around exon 1 of Pvt1, with a main cluster of 78 integrations. Tumors assayed by quantitative PCR (as shown in Figs. 4A to C) are numbered and noted in black text. The locations of the Taqman probes for measuring Pvt1 transcript levels are indicated by the red boxes on mRNA AK030859.
###end p 24
###begin p 25
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the <italic>Pvt1 </italic>and <italic>Myc </italic>transcripts. (A) </bold>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 310 314 310 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 410 414 410 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Expression of the Pvt1 and Myc transcripts. (A) Relative expression of exon 1 of Pvt1, as measured by quantitative PCR with the 5' primer set depicted in Fig. 3. Tumors numbered 1 through 28 as selected in Fig. 3; control tumors contain integration sites at locations in the genome other than the Pvt1 region. (B) Relative expression of AK030859 of Pvt1, as measured with the 3' primer set depicted in Fig. 3. (C) Relative expression of exon 2/3 junction of Myc, as measured by quantitative PCR. Tumor controls, tumors with insertions at sites other than the Myc or Pvt1 locus; normal controls, spleen and thymus cells from mockinjected (no virus) animals.
###end p 25
###begin p 26
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic representation of the genomic locations of the mouse miRNAs encoded by the <italic>Pvt1 </italic>locus</bold>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Schematic representation of the genomic locations of the mouse miRNAs encoded by the Pvt1 locus. Numbers above the red triangles, insertion sites of the tumors tested for miRNA expression; hairpins, location of miRNAs; bars in red below the scale, retroviral integration clusters reported in this study. Below the schematic, genomic sequence of miRNAs and their flanking sequences. The mature miRNA sequences are shown in red.
###end p 26
###begin p 27
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
Integration sites of tumors assayed for Pvt1 exon 1 transcript, and for Pvt1-encoded miRNA expression
###end p 27
###begin p 28
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Sites as defined by mm8 version of genome. Orientation, either "+" or "-", of the proviral insert (tag, denoted as T) relative to the direction of the genome display, and to the Pvt1 transcript ("gene", denoted as G, here always G+).
###end p 28
###begin p 29
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Because transcript AK030859 seems to represent a (less frequent) alternative splice product of the putative nuclear transcript, we also performed qPCR analyses with a primer set covering the 3' end of AK030859 (see right boxed area in Fig. 3). In these analyses, tumors with insertions at the Pvt1 locus on average expressed more AK030859 sequences than the control tumors, (Fig. 4B) (the control tumors are not listed in Table 1).
###end p 29
###begin title 30
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
Most T lymphomas express Myc, regardless of the location of retroviral integration sites
###end title 30
###begin p 31
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 654 658 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 823 828 823 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 926 930 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1065 1070 1065 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1080 1084 1080 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
It is possible that the common integration site at the Pvt1 locus is not actually due to selection for tumorigenesis via Pvt1, but to preferred (yet unknown) integration sequences at this locus. In this view, the increased Pvt1 expression would be of no biological consequence, but the insertions actually would increase Myc expression directly. We thus investigated Myc expression in tumors with insertions at the Myc and Pvt1 locus, respectively, and compared them to tumors without insertions at either of these loci; and to normal spleen cells or thymocytes from mock infected (i. e., no virus) mice. Clearly, the normal cell controls expressed less Myc than the tumors (Fig. 4C). But by and large, there was not much difference in Myc expression among the tumors, whether they had an insertion into the Myc locus, the Pvt1 locus, or no such insertion (Fig. 4C). Thus the SL3-3 induced T lymphomas generally have elevated Myc expression, no matter by which insertion that is accomplished, and there is no obvious correlation between location of insert into the Pvt1 locus and Myc expression.
###end p 31
###begin p 32
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 492 495 <span type="species:ncbi:11786">MLV</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
It is surprising that although only 6% of the T lymphomas have insertions directly into the Myc locus, almost all T lymphomas overexpress Myc as compared to normal splenocytes and thymocytes, whether there are insertions into the Myc locus, Pvt1 locus, or into an unknown site. This fact could be taken as an indication that retroviral integrations are capricious and not always the driving force of tumorigenesis. However, we interpret these data to mean that there may be a requirement for MLV induced T lymphomas in BALB/c mice to overexpress Myc, regardless of how this is achieved.
###end p 32
###begin title 33
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
Identity and expression of miRNAs encoded within the Pvt1 region
###end title 33
###begin p 34
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 236 241 236 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 867 940 867 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmu-mir-1204, mmu-mir-1205 mmu-mir-1206, mmu-mir-1207-5p, mmu-mir-1207-3p</italic>
###xml 946 958 946 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmu-mir-1208</italic>
###xml 1194 1203 1194 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mir-1204 </italic>
###xml 1218 1222 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1271 1280 1271 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1208 </italic>
###xml 1457 1458 1457 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 481 491 <span type="species:ncbi:9598">chimpanzee</span>
###xml 501 506 <span type="species:ncbi:10090">mouse</span>
###xml 511 514 <span type="species:ncbi:10116">rat</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 600 605 <span type="species:ncbi:9606">human</span>
###xml 727 732 <span type="species:ncbi:10090">mouse</span>
###xml 777 782 <span type="species:ncbi:10090">mouse</span>
###xml 838 843 <span type="species:ncbi:10090">mouse</span>
###xml 1011 1016 <span type="species:ncbi:10090">mouse</span>
Although at the time of manuscript preparation no miRNAs were listed in the miRNA registry of the The Wellcome Trust Sanger Institute [31,32] that map to the Pvt1 locus, the expressed sequence tag pattern indicated the possibility that Pvt1 does encode miRNAs. Indeed, using previously described algorithms that use sequence conservation of putative seed sequences and secondary structural properties of the putative miRNA hairpin structures, Pvt1-based miRNA candidates in human, chimpanzee, canine, mouse and rat have been identified [28], and confirmed experimentally in human and mouse [28]. The human miRs have recently been given designations by the Sanger miRBase, and we have adopted the analogous nomenclature for the mouse miRs. Fig. 5 shows the genomic sequences of mouse Pvt1 associated miRNAs and their flanking sequences in mouse; the miRNAs are called mmu-mir-1204, mmu-mir-1205 mmu-mir-1206, mmu-mir-1207-5p, mmu-mir-1207-3p, and mmu-mir-1208. Because in the following, we are only dealing with mouse sequences, we will omit the pre-fix "mmu." The mature miRNA sequences are shown in red. Above the sequences, their relative genomic locations, on chromosome 15, are shown. With mir-1204 closest to the Myc locus, at a distance of approximately 50 kb, and miR-1208 furthest away (305 kb), the pvt-1 primary RNA, if a single transcript, spans at least 255 kb. The exact genomic locations of the Pvt1-encoded miRNA sequences are given in Table 2.
###end p 34
###begin p 35
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Genomic locations of the mouse Pvt1-encoded miRNA sequences on chromosome 15, as given by the mm8 and mm9 genome versions.
###end p 35
###begin p 36
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 435 444 435 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1206 </italic>
###xml 489 497 489 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1204</italic>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1205</italic>
###xml 509 534 509 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1207-5p, miR-1207-3p </italic>
###xml 538 546 538 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1208</italic>
###xml 594 603 594 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mir-1204 </italic>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1021 1026 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 1259 1264 1254 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
To determine if the retroviral integrations altered expression of these Pvt1 associated miRNAs, we measured the expression of the mature species of the five miRNAs by qRT-PCR using a stem-loop RT primer specific for each miRNA [24,33], in tumors with and without Pvt1 insertions (Table 3). For standardization, we compared them to known concentrations of synthesized miRNAs of the relevant sequence. While we could detect a signal for miR-1206 only in one tumor, we did find expression of miR-1204, miR-1205, miR-1207-5p, miR-1207-3p and miR-1208, albeit at quite different levels. On average, mir-1204 was most pronounced as it was expressed nearly four times more in tumors with Pvt1 inserts than in the control tumors (Table 3; Deltamu 0.05) - irrespective of the site of retroviral integration within the Pvt1 locus. Because thymocytes and spleen cells represent a mixture of many cells, one cannot directly compare these cells with the tumor cells. Nevertheless, we note that the expression level in the tumors with Pvt1 integrations was not significantly different from thymocytes and non-stimulated spleen cells. It therefore seems as if this miRNA is required for cell survival. The relatively modest overexpression in tumors with insertions into the Pvt1 locus may be a consequence of the retroviral enhancer, but the tumorigenicity of the provirus may be mediated by the persistence of miRNA expression rather than by its overexpression.
###end p 36
###begin p 37
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
QPCR measuring mmu-miRNAs encoded by Pvt1.
###end p 37
###begin p 38
Numbers in the first column correspond to the tumour numbers in the Table 1; other columns represent the cycle numbers needed to reach a predetermined threshold. BT, below threshold; ND, not done; STD, standard deviation. A cycle number of 30 corresponds to approximately 3000 molecules per cell.
###end p 38
###begin p 39
###xml 9 18 9 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1205 </italic>
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1208 </italic>
###xml 258 267 258 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1205 </italic>
###xml 335 344 335 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1205 </italic>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 415 424 415 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1205 </italic>
###xml 508 517 508 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1206 </italic>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 944 953 944 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1206 </italic>
###xml 1103 1119 1103 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmu-miR-1207-5p </italic>
###xml 1167 1179 1167 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1207-5p </italic>
###xml 1183 1195 1183 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1207-3p </italic>
###xml 1244 1249 1244 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 573 578 <span type="species:ncbi:10090">mouse</span>
Although miR-1205 and miR-1208 gave clear signals, the threshold was only reached after 40 cycles, making the significance of these miRNAs in tumorigenesis less clear. However, in three tumors (#31, #32, #34) with integrations close to its genomic position, miR-1205 is expressed more than in other tumors; and the expression level of miR-1205 in thymus (34 cycles to reach threshold; Table 3) makes it likely that miR-1205 plays a role in normal cell differentiation. In most of the tumors, we did not find miR-1206 expression; although precursor RNA was increased in the mouse myeloma MOPC104E [28], we did not find the mature miRNA expressed (not shown). In fact, there was also no expression in thymocytes and spleen cells, but tumor 16 gave a clear and reproducible signal. Since this tumor does not differ in its integration site or proviral transcriptional orientation from other tumors with insertions in this region, we think that the miR-1206 expression is not mediated by the provirus. Rather it may be the effect of another mutational event, which in myelomas is more frequent. The level of mmu-miR-1207-5p was relatively low in thymus; but the levels of miR-1207-5p and miR-1207-3p in tumors with and without integrations into the Pvt1 locus did not differ much, and thus we cannot correlate expression of these miRs with an oncogenic event. In all the tumors, it is possible that the other allele (with no proviral integration) contributes to the miRNA levels, which may mask differences.
###end p 39
###begin p 40
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1206</italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 854 862 854 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">miR-1208</italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 938 947 938 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mir-1204 </italic>
###xml 931 937 <span type="species:ncbi:10090">murine</span>
Overall we can conclude that except perhaps for miR-1206, the other Pvt1 encoded miRNAs are expressed in T-lymphocytes. However, we have not yet performed a detailed analysis of the consequences of the various proviral integrations sites. We can assume that the exon 1 overexpressing tumors end their transcripts with the retroviral termination site and poly A tail, which would exclude all the downstream miRNAs. However, the 3' retroviral promoter may also restart a transcript, as has been discussed for integrations into the Notch1 locus [34]. An indication for this is the fact that the qPCR primers covering the the 3' end of the intron-less transcript AK030859, also measured increased expression levels in tumors with insertions between the DNA segments of probe sets 1 and 2. At any rate, we feel justified in concluding that except perhaps for miR-1208, all other Pvt1 encoded miRNAs do exist, and that it is likely that murine mir-1204 is oncogenic in T lymphomas when constitutively expressed.
###end p 40
###begin title 41
Co-mutation analysis
###end title 41
###begin p 42
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1846 1848 1846 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1922 1923 1922 1923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 2010 2018 <span type="species:ncbi:9606">patients</span>
It is well established that tumorigenesis is the result of accumulating several cooperating mutations that drive relentless proliferation and aid in metastases. Co-mutation analyses, where one oncogenic event is fixed by means of a transgene in the mouse to be infected with retrovirus, were very successful in identifying cooperating oncogenes, for example with Myc [14], or with p27Kip1 loss [19]. Without fixing any event by a transgene, viral insertional mutagenesis, though perhaps not providing all the mutations necessary for a full-blown tumor, follows the multistep scenario of tumorigenesis. Although in general the superinfection barrier largely prevents multiple proviral integrations within the same cell, re-infection does happen over time. Because it is a rare event, such cells are selected over the others only when these integrations also give a growth advantage. As a consequence, in general, most viral insertions ("co-mutations") in a single tumor are thought to be causative in its formation. With the caveats of potential passenger mutations and potential oligoclonality of tumors, co-mutation analysis may be a powerful way to find cooperating signaling pathways in tumorigenesis. For this analysis, the following two rules can be stated: (i) genes that are co-mutated in a single cancer cell represent different pathways that cooperate during carcinogenesis; and (ii) genes within the same pathway are never co-mutated. These rules assume "linear," non-branched pathways, which is a gross oversimplification. They also assume that it does not help to turn on a pathway (twice) by two integrations rather than one, but, of course, increased signal strength may indeed help tumorigenesis. For example, an obvious exception is Notch1, for which two mutations have been shown to lead to more aggressive growth than just one [35] - a fact that is reflected by our finding of three double mutants (Fig. 6; and unpublished), with mutations in the same two domains that are also co-mutated in patients. Nevertheless, if in a large sample set, one never finds two genes co-mutated, it seems fairly safe to assume that they are in the same pathway.
###end p 42
###begin p 43
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Matrix for co-mutation analysis</bold>
Matrix for co-mutation analysis. Only a partial view is given. The numbers (color blue, underlined) represent the oncogenes/tumor suppressor genes detected in the T lymphoma screen, in the order of their incidence, horizontally and vertically. The numbers in the boxes at the intersections (color black) indicate the number of tumors the cancer genes were found in the same tumor.
###end p 43
###begin p 44
###xml 5 6 5 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 833 838 833 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 887 892 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1129 1130 1129 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
###xml 539 542 <span type="species:ncbi:11786">MLV</span>
Fig. 6 shows a matrix for co-mutation analysis, here focusing on Pvt1. The numbers (color blue, underlined) represent the frequency of tagged oncogenes/tumor suppressor genes detected in the T lymphoma screen, in the order of their incidence, horizontally and vertically. The numbers in the boxes at the intersections (color black) indicate the number of tumors the cancer genes were found in the same tumor. In this matrix, Pvt1 is represented by number 3, i.e., it is the third most frequent cancer locus in mouse T lymphomas mutated by MLV. The other high frequency tagged genes (1, 2, 4, 5, 6 and 7) are Evi5, Notch1, Rasgrp1, Ahi1, Gfi1 and Myc, respectively. Because they are found together with Pvt1 in a number of tumors, these genes are all co-mutations, except for Myc - there are no tumors with insertions to both Myc and Pvt1 loci. By the logic above, this apparently places Pvt1 and Myc into the same pathway, although from this analysis it cannot be determined which one of the genes is upstream. Another indication for the two genes sharing a pathway comes from the fact that they have the same co-mutations (Fig. 6); and that they both do not co-mutate with gene 21, which thus ought to be in the same pathway as well.
###end p 44
###begin p 45
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
###xml 261 266 <span type="species:ncbi:10090">mouse</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
With 11% of the 2199 T lymphomas studied having insertions within it, the pathway pvt is part of what seems to be one of the most important regulators of T lymphomagenesis in the BALB/c mouse strain, and, by extension, perhaps also in Burkitt's lymphoma and in mouse plasmacytomas, as these are clearly driven by the translocations involving the Myc and Pvt1 loci. If so, it seems peculiar that in our screen with Akv, which induces B cell lymphomas in NMRI mice, only one out of 1798 tags were in the Myc locus, and none in the Pvt1 locus. Similarly, among the resulting 24 tumors analyzed by Lovmand et al. [15], only one tumor, containing an Akv variant, harbored a clonal proviral integration in the c-Myc locus. Because most cells, including B cells, express the Akv receptor, the reason for this may lie in the differentiation stage of the infected cell.
###end p 45
###begin title 46
Conclusion
###end title 46
###begin p 47
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 659 664 659 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PVT1 </italic>
Part of the complexity in determining the functional significance of the Pvt1 locus stems from the fact that Pvt1 is closely linked to the Myc locus. Translocations directly into the Myc locus change expression levels of Myc, and thus easily explain their contribution to oncogenesis; but the breakpoints of variant translocations into the Pvt1 locus extend up to 400 kb downstream of Myc, and they also have been thought to cause overexpression of Myc as well. Because the Pvt1 transcript encodes no protein, the effect on Myc was thought to be direct, and, therefore, long range [4]. On the other hand, the multiple myeloma cases with translocations in the PVT1 locus without immunoglobulin gene translocation would argue for this locus to be oncogenic in its own right, as do the retroviral integrations into this locus.
###end p 47
###begin p 48
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 761 764 761 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 818 827 818 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mir-1204 </italic>
###xml 893 897 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 984 988 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 1020 1025 1020 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1 </italic>
###xml 830 835 <span type="species:ncbi:10090">mouse</span>
In this paper, we present a large number of tumors with retroviral integrations into the Pvt1 locus, which thus can be regarded as oncogenic, particularly as these integration events are associated with overexpression of Pvt1 transcripts. We also confirm that the Pvt1 locus encodes miRNAs, and that retroviral insertion can lead to altered expression of at least one of these miRNAs. From the co-mutation analysis, we also conclude that Pvt1 and Myc are likely in the same pathway; this may mean that any of the miRNAs directly determine Myc transcript levels by siRNA-type mediated degradation; or, because there is no clear binding site for any of these miRNAs in the 3'UTR of Myc, more likely by regulating the translation of upstream factors that activate Myc. Consistent with this hypothesis, over-expression of mir-1204 in mouse pre-B cells, but not in pro-B cells, appears to increase Myc expression [28] - apparently in a cell type and/or stage specific fashion. Conversely, Myc may also regulate the levels of Pvt1 encoded miRNAs. Which of these alternatives is the case may be decided once the targets of the miRNAs are known.
###end p 48
###begin title 49
Methods
###end title 49
###begin title 50
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Retroviral induction of tumors of mice
###end title 50
###begin p 51
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">Mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
BOSC23 retroviral packaging cells were transfected with plasmids encoding the complete SL3-3 provirus. Viral particles from culture supernatant were injected intraperitoneally into newborn (<3 days) BALB/c mice. The fathers of the injected mice were also mutagenized by ethyl-nitroso-urea as part of another study [36]. Mice were monitored everyday for general sickness as well as tumor development. When sickness or tumors of defined size were discovered, mice were euthanized and tumors of the spleen and thymus were removed and frozen at -80degreesC.
###end p 51
###begin title 52
Identification of provirus integration sites
###end title 52
###begin p 53
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
The genomic locations of the proviral integrations were determined using the splinkerette-based PCR method [37]. This method recovers genomic DNA directly flanking the 5' LTR of the integrated provirus. Genomic DNA was isolated from tumors using the DNeasy Tissue kit (Qiagen) and digested using restriction enzymes BstYI or NspI. A double-stranded splinkerette adapter molecule [38] containing the appropriate restriction site was ligated to the digested genomic DNA using the Quick Ligation kit (New England Biolabs). These ligation products were then digested with EcoRV to prevent subsequent amplification of internal viral fragments. The resulting mixture was purified using QIAquick PCR purification kits (Qiagen), and subject to three rounds of PCR using nested PCR primers that had homology to the adapter DNA and to the 5' LTR sequence of the SL3-3 virus. After resolving the PCR products by gel electrophoresis, the desired bands were purified using QIAquick Gel Extraction kits (Qiagen) and subject to standard DNA sequencing.
###end p 53
###begin title 54
Quantitative PCR of primary RNA transcripts
###end title 54
###begin p 55
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvt1</italic>
###xml 983 986 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Total RNA was extracted from frozen mouse spleen and thymus tumor samples using the RNeasy Mini Kit (Qiagen). All RNA samples were treated with rDNase (Ambion) prior to reverse transcription. 500 ng RNA from each tumor sample was reverse transcribed with random hexamers using the SuperScript First-Strand Synthesis System III (Invitrogen). qPCR was conducted on the Stratagene MX3000P using Brilliant SYBR Green qPCR Master Mix (Stratagene). SYBR qPCR primers were designed using Beacon Designer 5.0 from Premier Biosoft and ordered from Integrated DNA Technologies. Beta-actin (ACTB) served as an endogenous control gene for all SYBR qPCR runs. qPCR primers were as follows: ACTB: 5'-TTCCAGCCTTCCTTCTTG-3', 5'-GGAGCCAGAGCAGTAATC-3'; Pvt1-exon1: 5'-(GAGCACAT)GGACCCACTG-3' (it contains 8 bp of genomic sequence before the start of AK090048 exon1, genomic part in parenthesis); 5'-GCTGCCAACATCCTTTCC-3'; AK030859 (3'end): 5'-GGCACAAGAGAACCAAGTCC-3', 5'-CGCTTATCCTCCTGCTTCAAC-3'; and Myc-ExJ2-3: 5'-GACACCGCCCACCACCAG-3', 5'-GCCCGACTCCGACCTCTTG-3'.
###end p 55
###begin p 56
###xml 555 568 512 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;Ct</sup>
The qPCR reaction mixture contained 150 nM (final concentration) of each primer and the appropriate dilution of cDNA for each target studied in a final qPCR reaction volume of 25 mul. PCR cycling was as follows: 95degreesC 10 min; 40 cycles of 95degreesC 30 sec, Ta (annealing) of 55 to 60degreesC 60 sec, 72degreesC 30-45 seconds; followed by a denaturation cycle of 95degreesC 60 sec, 55degreesC 30 sec, 95degreesC 30 sec. Tumor samples containing no integration sites in the region of interest were used as control tumors. Relative expression values (2-DeltaDeltaCt) were calculated using control tumor 1 as a calibrating sample. All relative expression values were then normalized to set the average of the tumor controls to a value of 1 for each target.
###end p 56
###begin title 57
Quantitative PCR of miRNAs
###end title 57
###begin p 58
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
MiRNAs and low molecular weight RNAs were isolated from frozen mouse tumor tissue using the Purelink miRNA Isolation Kit (Invitrogen). The mature species of the miRNAs were measured by RT-qPCR using a stem-loop RT primer specific for each miRNA [33] in the cells listed, in triplicates. Accordingly, 50 ng of each tumor miRNA preparation was reverse transcribed with the SuperScript III First-Strand Synthesis System for RT-PCR using the following stem loop RT primers (50 nM final concentration) 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCACT-3'(mmu-mir-1204), 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCTCAAA-3'(mmu-mir-1205), 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACTTAA-3' (mmu-mir-1206), 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCCTTC-3'(mmu-mir-1207-5p), 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGAGATG-3'(mmu-mir-1207-3p) and 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCAGCC-3'(mmu-mir-1208). The reverse transcription reactions were diluted 1:5 and 5 mul of these dilutions were used in the 25 mul qPCR reactions. The annealing step was 50degreesC for 60s. The qPCR probes and primers were as follows: mmu-mir-1204: 5'-GCGGTGGTGGCCTGCTCT-3', 5'-GTGCAGGGTCCGAGGT-3', 5'-[56-FAM]-CACTGGATACGACAGCACTG-[36-TAMSp]-3'; mmu-mir-1205: 5'-GGCGTCTGCAGGACTGG-3', 5'-GTGCAGGGTCCGAGGT-3', 5'-[56-FAM]-CACTGGATACGACCTCAAAG-[36-TAMSp]-3', mmu-mir-1206: 5'-TTGCGGTATTCACTTGGG-3', 5'-GTGCAGGGTCCGAGGT-3', 5'-[56-FAM]-CACTGGATACGACACTTAAACA-[36-TAMSp]-3'; mmu-mir-1207-5p: 5'-TGCTGGCACGGTGGGTG-3', 5'-GTGCAGGGTCCGAGGT-3', 5'-[56-FAM]-CACTGGATACGACCCCTTCC-[36-TAMSp]-3'; mmu-mir-1207-3p: 5'-TGTCTGTCAGCTGGCCT-3', 5'-GTGCAGGGTCCGAGGT-3', 5'-[56-FAM]-CACTGGATACGACGAGATGA-[36-TAMSp]-3'; mmu-mir-1208: 5'-CCGGTCACTGTTCAGAC-3', 5'-GTGCAGGGTCCGAGGT-3', 5' [56-FAM]-CACTGGATACGACCCAGCCT-[36-TAMSp]-3'.
###end p 58
###begin p 59
Synthetic RNA oligos (IDT) were used to generate a calibration curve for each miRNA; for mmu-mir-1204, 5'-UGGUGGCCUGCUCUCAGUGCU-3'; mmu-mir-1205, 5'-UCUGCAGGACUGGCUUUGAG-3'; mmu-mir-1206, 5'-UAUUCACUUGGGUGUUUAAGU-3'; mmu-mir-1207-5p, 5'-UGGCACGGUGGGUGGGAAGGG-3'; mmu-mir-1207-3p, 5'-UCAGCUGGCCUUCAUCUC3'-3'; and mmu-mir-1208, 5'-UCACUGUUCAGACAGGCUGG-3'. Amplification efficiencies of the calibration curves for the 6 mmu-mirs were at least 70%. Concentrations of the mature species were calculated using the calibration curves and then normalized by the average of the control tumors, to calculate relative expression levels.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
GBB designed and carried out the quantitative PCR experiments for the miRNAs; AML designed and carried out the quantitative PCR experiments for the primary RNA transcripts and helped in the drafting of the manuscript; KH and NJC previously identified the mouse miRNA-PVT sequences, and KH was intimately involved in discussions about the ongoing work and helped with the manuscript; BBW carried out the tag recovery and identification; BBW and MW planned and directed the execution of the retroviral screen and the design of the study, and MW wrote the manuscript.
###end p 61
###begin title 62
Acknowledgements
###end title 62
###begin p 63
Supported by NIH grant R01CA100266 and by the Intramural Research Program of the National Cancer Institute, NIH, Center for Cancer Research. We thank Gabor Bartha, Lauri Li, Namitha Channa for help with tag recovery and identification; and Finn Pedersen for advice and discussion.
###end p 63
###begin article-title 64
###xml 35 41 <span type="species:ncbi:10090">murine</span>
Variant (6; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene
###end article-title 64
###begin article-title 65
###xml 20 25 <span type="species:ncbi:9606">human</span>
Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma
###end article-title 65
###begin article-title 66
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Pvt-1 transcripts are found in normal tissues and are altered by reciprocal(6;15) translocations in mouse plasmacytomas
###end article-title 66
###begin article-title 67
Effects of translocations on transcription from PVT
###end article-title 67
###begin article-title 68
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
Chimeric transcripts with an open reading frame are generated as a result of translocation to the Pvt-1 region in mouse B-cell tumors
###end article-title 68
###begin article-title 69
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas
###end article-title 70
###begin article-title 71
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations
###end article-title 71
###begin article-title 72
###xml 88 117 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
###xml 126 129 <span type="species:ncbi:10116">rat</span>
Rearrangement of a DNA sequence homologous to a cell-virus junction fragment in several Moloney murine leukemia virus-induced rat thymomas
###end article-title 72
###begin article-title 73
###xml 35 38 <span type="species:ncbi:10116">rat</span>
###xml 101 107 <span type="species:ncbi:10090">murine</span>
Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas
###end article-title 73
###begin article-title 74
###xml 59 62 <span type="species:ncbi:11864?0.898989898989899">ALV</span>
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
###end article-title 74
###begin article-title 75
###xml 27 52 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome
###end article-title 75
###begin article-title 76
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15
###end article-title 76
###begin article-title 77
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging
###end article-title 77
###begin article-title 78
###xml 33 56 <span type="species:ncbi:11786">murine leukemia viruses</span>
B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer
###end article-title 78
###begin article-title 79
Leukaemia disease genes: large-scale cloning and pathway predictions
###end article-title 79
###begin article-title 80
New genes involved in cancer identified by retroviral tagging
###end article-title 80
###begin article-title 81
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice
###end article-title 81
###begin article-title 82
Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis
###end article-title 82
###begin article-title 83
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
###end article-title 83
###begin article-title 84
Retroviral insertional mutagenesis: past, present and future
###end article-title 84
###begin article-title 85
###xml 39 59 <span type="species:ncbi:11864">avian leukosis virus</span>
Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events
###end article-title 85
###begin article-title 86
Activation of an oncogenic microRNA cistron by provirus integration
###end article-title 86
###begin article-title 87
Retroviral activation of the mir-106a microRNA cistron in T lymphoma
###end article-title 87
###begin article-title 88
###xml 39 44 <span type="species:ncbi:9606">human</span>
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
###end article-title 88
###begin article-title 89
microRNAs in viral oncogenesis
###end article-title 89
###begin article-title 90
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Molecular cloning of a highly leukemogenic, ecotropic retrovirus from an AKR mouse
###end article-title 90
###begin article-title 91
###xml 68 73 <span type="species:ncbi:9606">human</span>
The identification of microRNAs in a genomically unstable region of human chromosome 8q24
###end article-title 91
###begin article-title 92
RTCGD: retroviral tagged cancer gene database
###end article-title 92
###begin article-title 93
Characterization of virus produced by a lymphoma induced by inoculation of AKR MCF-247 virus
###end article-title 93
###begin article-title 94
miRBase: the microRNA sequence database
###end article-title 94
###begin article-title 95
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
New human and mouse microRNA genes found by homology search
###end article-title 95
###begin article-title 96
Real-time quantification of microRNAs by stem-loop RT-PCR
###end article-title 96
###begin article-title 97
###xml 93 108 <span type="species:ncbi:10090">transgenic mice</span>
Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice
###end article-title 97
###begin article-title 98
###xml 34 39 <span type="species:ncbi:9606">human</span>
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
###end article-title 98
###begin article-title 99
###xml 68 89 <span type="species:ncbi:11786">murine leukemia virus</span>
A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus
###end article-title 99
###begin article-title 100
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
###end article-title 100
###begin article-title 101
Splinkerettes - improved vectorettes for greater efficiency in PCR walking
###end article-title 101

